SHOCKWAVE MEDICAL INC (SWAV) Stock Price, Quote, News and Overview
NASDAQ:SWAV - Nasdaq - US82489T1043 - Common Stock - Currency: USD
SWAV Quote, Performance and Key Statistics
334.75
-0.08 (-0.02%)
The current stock price of SWAV is 334.75 USD. In the past month the price increased by 1.49%. In the past year, price increased by 15.77%.
SWAV Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 26.96 | 223.47B | ||
| ISRG | INTUITIVE SURGICAL INC | 67.35 | 184.36B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.74 | 150.72B | ||
| SYK | STRYKER CORP | 29.95 | 139.34B | ||
| MDT | MEDTRONIC PLC | 15.76 | 107.94B | ||
| BDX | BECTON DICKINSON AND CO | 14.74 | 58.89B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.25 | 44.70B | ||
| IDXX | IDEXX LABORATORIES INC | 38.88 | 35.45B | ||
| RMD | RESMED INC | 25.98 | 34.64B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.24 | 31.33B | ||
| DXCM | DEXCOM INC | 43.43 | 28.10B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 15.94 | 23.53B |
Related stock screener links
About SWAV
Company Profile
Shockwave Medical, Inc. operates as a medical device company, which focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The company is headquartered in Santa Clara, California and currently employs 1,001 full-time employees. The company went IPO on 2019-03-07. The firm is focused on development and commercialization of products intended to transform the way calcified cardiovascular disease is treated. The company provides care for the treatment of calcified cardiovascular disease through its differentiated local delivery of sonic pressure waves, intravascular lithotripsy (IVL). Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD. Its Shockwave L6 IVL catheter is a six-emitter catheter for use in its IVL System in large diameter vessels for the treatment of PAD. Its Shockwave C2 IVL catheter and Shockwave C2+ IVL catheter are two-emitter catheters for use in its IVL System for the treatment of coronary artery disease (CAD).
Company Info
SHOCKWAVE MEDICAL INC
5403 Betsy Ross Dr
Santa Clara CALIFORNIA 95054 US
CEO: Douglas Godshall
Employees: 1001
Company Website: https://shockwavemedical.com/
Phone: 15102794262
SHOCKWAVE MEDICAL INC / SWAV FAQ
What is the stock price of SHOCKWAVE MEDICAL INC today?
The current stock price of SWAV is 334.75 USD. The price decreased by -0.02% in the last trading session.
What is the ticker symbol for SHOCKWAVE MEDICAL INC stock?
The exchange symbol of SHOCKWAVE MEDICAL INC is SWAV and it is listed on the Nasdaq exchange.
On which exchange is SWAV stock listed?
SWAV stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for SHOCKWAVE MEDICAL INC stock?
16 analysts have analysed SWAV and the average price target is 330.75 USD. This implies a price decrease of -1.19% is expected in the next year compared to the current price of 334.75. Check the SHOCKWAVE MEDICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is SHOCKWAVE MEDICAL INC worth?
SHOCKWAVE MEDICAL INC (SWAV) has a market capitalization of 12.57B USD. This makes SWAV a Large Cap stock.
How many employees does SHOCKWAVE MEDICAL INC have?
SHOCKWAVE MEDICAL INC (SWAV) currently has 1001 employees.
What are the support and resistance levels for SHOCKWAVE MEDICAL INC (SWAV) stock?
SHOCKWAVE MEDICAL INC (SWAV) has a support level at 334.46 and a resistance level at 334.76. Check the full technical report for a detailed analysis of SWAV support and resistance levels.
Is SHOCKWAVE MEDICAL INC (SWAV) expected to grow?
The Revenue of SHOCKWAVE MEDICAL INC (SWAV) is expected to grow by 27.69% in the next year. Check the estimates tab for more information on the SWAV EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy SHOCKWAVE MEDICAL INC (SWAV) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of SWAV, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of SWAV, evaluating the profitability, health, valuation and growth aspects
- SHOCKWAVE MEDICAL INC (SWAV) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SHOCKWAVE MEDICAL INC (SWAV) Sales and EPS estimates to see what analysts future expectations are.
- SHOCKWAVE MEDICAL INC (SWAV) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SHOCKWAVE MEDICAL INC (SWAV) Insider and Institutional Ownership to learn about the owners and their transactions.
- SHOCKWAVE MEDICAL INC (SWAV) Stock Chart to make your own analysis
- SHOCKWAVE MEDICAL INC (SWAV) Latest news and press-releases to stay up to date.
Does SHOCKWAVE MEDICAL INC (SWAV) stock pay dividends?
SWAV does not pay a dividend.
When does SHOCKWAVE MEDICAL INC (SWAV) report earnings?
SHOCKWAVE MEDICAL INC (SWAV) will report earnings on 2024-08-05, after the market close.
What is the Price/Earnings (PE) ratio of SHOCKWAVE MEDICAL INC (SWAV)?
The PE ratio for SHOCKWAVE MEDICAL INC (SWAV) is 78.21. This is based on the reported non-GAAP earnings per share of 4.28 and the current share price of 334.75 USD. Check the full fundamental report for a full analysis of the valuation metrics for SWAV.
SWAV Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to SWAV. When comparing the yearly performance of all stocks, SWAV is one of the better performing stocks in the market, outperforming 87.72% of all stocks.
SWAV Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to SWAV. While SWAV has a great health rating, its profitability is only average at the moment.
SWAV Financial Highlights
Over the last trailing twelve months SWAV reported a non-GAAP Earnings per Share(EPS) of 4.28. The EPS increased by 12.34% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 20.76% | ||
| ROA | 9.95% | ||
| ROE | 21.76% | ||
| Debt/Equity | 0.97 |
SWAV Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 54% to SWAV. The Buy consensus is the average rating of analysts ratings from 16 analysts.
For the next year, analysts expect an EPS growth of 36.11% and a revenue growth 27.69% for SWAV